CNE000001BG9
CNE000001BG9
SHANDONG PHARMACEUTICAL GLASS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.474.018.979 | 4.904.912.356 | 8.8% |
| Cost of Revenue | 2.983.735.053 | 3.278.980.192 | 9.0% |
| Gross Profit | 1.490.283.925 | 1.625.932.164 | 8.3% |
| 543.765.411 | 525.293.698 | 3.5% | |
| Operating Income | 946.518.514 | 1.100.638.465 | 14.0% |
| Pretax Income | 830.828.069 | 1.110.805.053 | 25.2% |
| Net Income Common Stockholders | 689.626.041 | 942.991.305 | 26.9% |
| -- | -- | -- | |
| -- | -- | -- |